Atlas Trials

Open-label, Single-arm Study to Assess the Pharmacokinetics, Safety, and Tolerability of a Single Subcutaneous Dose of Icatibant in Healthy Japanese Volunteers

Clinical trial NCT02045264 · COMPLETED

Trial details

NCT number
NCT02045264
Sponsor
Shire
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Hereditary Angioedema (HAE)
Start date
2014-02-21
Primary completion
2014-02-27
Enrollment
12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.